ResearcherLanzhou University Second HospitalActive in the last 2 years
Cheng Yu
Matched on ORCID iD 0000-0002-9227-3764; OpenAlex author ID A5101295003. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2024: 3 papers
Papers 3
- Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line. Co-author DOI 10.1007/s13577-024-01100-y↗
- A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-56464-w↗
- Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. Co-author DOI 10.1186/s12885-024-12588-w↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Changpeng Chai · 3 shared papers, 2024 · strength 0.55
- Paper A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-56464-w↗
- Paper Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. DOI 10.1186/s12885-024-12588-w↗
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Hao Xu · 3 shared papers, 2024 · strength 0.55
- Paper A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-56464-w↗
- Paper Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. DOI 10.1186/s12885-024-12588-w↗
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Huan Tang · 3 shared papers, 2024 · strength 0.55
- Paper A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-56464-w↗
- Paper Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. DOI 10.1186/s12885-024-12588-w↗
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Wence Zhou · 3 shared papers, 2024 · strength 0.55
- Paper A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-56464-w↗
- Paper Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. DOI 10.1186/s12885-024-12588-w↗
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Bo Zhang · 1 shared paper, 2024 · strength 0.18
- Zhengfeng Wang · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.